Clinical Research Coordinator, Profamilia, Bogotá, Colombia.
Clinical Research Analyst, Profamilia, Bogotá, Colombia.
Contraception. 2024 Oct;138:110514. doi: 10.1016/j.contraception.2024.110514. Epub 2024 Jun 13.
To compare the effectiveness and safety of medication abortion (MAB) via telemedicine versus in-person in pregnant people with less than 12 gestational weeks in Colombia.
A retrospective cohort study was conducted with 23,362 pregnant people who requested MAB service from Profamilia (a Colombian non-governmental organization) in 2021-2022. The outcomes were success and safety of MAB. We performed a descriptive and a multivariate statistical analysis using the binary regression model to obtain an adjusted Odds Ratio (aOR) to identify factors associated with abortion success.
In comparison to in-person care (n = 20,289), individuals in telemedicine (n = 3073) were predominantly from urban areas, belonged to a lower socioeconomic stratum, single and did not identify with any ethnic group. In-person users tended to have higher levels of education and accessed the service through private insurance (p < 0,05). There were no differences in the odd of a successful abortion based on the modality of care (aOR 1.18; 95% CI=0.87-1.59). The results were also the same with sensitivity analysis stratified: pregnant people who were nine weeks gestation or less (aOR 0.86; 95% CI=0.63-1.17) or more (aOR 0.87; 95% CI=0.28-2.65).
Telemedicine is an effective and safe option for MAB, as in-person care. Telemedicine has the potential to increase abortion access by extending the availability of providers and offering people a new option for obtaining care conveniently and privately, especially for women with disadvantaged socioeconomic and educational background.
This study demonstrates that medication abortion (MAB) administered via telemedicine produces outcomes akin to those of in-person care, providing a compelling rationale for its adoption, particularly in underserved regions. This approach can be replicated in other countries in Latin America and the Caribbean.
比较哥伦比亚孕 12 周内人群通过远程医疗和面对面方式行药物流产(MAB)的有效性和安全性。
本回顾性队列研究纳入 2021-2022 年期间向哥伦比亚非政府组织 Profamilia 申请 MAB 服务的 23362 名孕妇,结局为 MAB 的成功和安全性。我们采用二元回归模型进行描述性和多变量统计分析,以获得调整后的优势比(aOR),以确定与流产成功相关的因素。
与面对面护理(n=20289)相比,远程医疗(n=3073)组的个体主要来自城市地区,属于较低社会经济阶层,单身,不认同任何种族群体。面对面使用者倾向于具有较高的教育水平,并通过私人保险获得服务(p<0.05)。基于护理模式,流产成功的可能性没有差异(aOR 1.18;95%CI=0.87-1.59)。分层敏感性分析的结果也相同:妊娠 9 周或以下(aOR 0.86;95%CI=0.63-1.17)或以上(aOR 0.87;95%CI=0.28-2.65)的孕妇也是如此。
远程医疗是 MAB 的一种有效和安全的选择,与面对面护理一样。远程医疗有可能通过扩大提供者的可用性并为人们提供一种方便和私下获得护理的新选择,特别是为社会经济和教育背景较差的妇女,增加流产机会。
本研究表明,通过远程医疗实施的药物流产(MAB)产生的结果与面对面护理相似,为其采用提供了有力的理由,特别是在服务不足的地区。这种方法可以在拉丁美洲和加勒比地区的其他国家复制。